ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program

January 16, 2017 updated by: Fondazione Don Carlo Gnocchi Onlus

ABILITY - TelerehABILITation. TechnologY-enhanced Multi-domain at Home Continuum of Care Program for People With Cognitive Impairment.

The Ability research project, funded in Italy within the Smart Cities and Smart Communities funding program (MInistry of University and Research, Operational Regional Programme, Lombardy, Axis 1, Operational Regional Programme - European Funding for Regional Development 2007-2013), aims at developing and testing the efficacy and the impact of a Personal Smart Health Community able to provide innovative trajectories for people with cognitive impairment, putting them at the core of a continuous and intertwining treatment and support from both formal (e.g. physicians) and informal (e.g. near relatives) caregivers, with special focus on home-based care.

Within this framework of the Ability project the investigators test the efficacy of the home-based motor-cognitive rehabilitation program delivered with two different approaches: the Ability platform versus the usual care program

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 85 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnosed as mild AD or MCI due to AD (Albert et al, 2011) according to DSM 5 diagnostic criteria (American Psychiatric Association, 2013);
  • MMSE score >18
  • school attendance (≥ 3 years).

Exclusion Criteria:

  • dysmetria;
  • serious deficits in visual acuity, acoustic perception, and in routine communication skills.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ability platform program
Multi-domain at home rehabilitation program delivered through the Ability platform.
The Ability program is an at home participant-tailored and technology-enhanced platform a) delivering tablet-based intensive (five days/a week for six weeks) motor and cognitive activities; b) monitoring from remote vital and physical health parameters (i.e., weight, Heart Rate, O2 saturation, daily steps, sleep activity).
Active Comparator: Usual care program
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
activities of daily living
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
Activities of Daily Living Inventory (ADCS/ADL)
change from baseline after 8 weeks (aMCI/AD subjects)
behavioral symptoms
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
Neuropsychiatric Inventory (NPI) score
change from baseline after 8 weeks (aMCI/AD subjects)
cognitive domain (long-term memory)
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
Free and Cued Selective Recall Test (FCSRT) score
change from baseline after 8 weeks (aMCI/AD subjects)
cognitive domain (language)
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
Fluency score
change from baseline after 8 weeks (aMCI/AD subjects)
cognitive domain (frontal-executive functions)
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
Trail Making Test (TMT) score
change from baseline after 8 weeks (aMCI/AD subjects)
quality of life
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
Dementia Quality of Life (D-QoL) Instrument
change from baseline after 8 weeks (aMCI/AD subjects)
coping strategies
Time Frame: change from baseline after 8 weeks (aMCI/AD subjects)
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
change from baseline after 8 weeks (aMCI/AD subjects)
global cognitive level
Time Frame: change from baseline after 12 months (aMCI/AD subjects)
Montreal Cognitive Asssessment (MoCA) score
change from baseline after 12 months (aMCI/AD subjects)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
activities of daily living
Time Frame: change from baseline after 12 months (aMCI/AD subjects)
Activities of Daily Living Inventory (ADCS/ADL)
change from baseline after 12 months (aMCI/AD subjects)
conversion rate MCI versus AD
Time Frame: change from baseline after 12 months (aMCI subjects)
conversion rate score
change from baseline after 12 months (aMCI subjects)
cognitive domain - long term memory
Time Frame: change from baseline after 12 months (aMCI/AD subjects)
Free and Cued Selective Recall Test (FCSRT) score
change from baseline after 12 months (aMCI/AD subjects)
cognitive domain - language
Time Frame: change from baseline after 12 months (aMCI/AD subjects)
Fluency score
change from baseline after 12 months (aMCI/AD subjects)
cognitive domain - frontal executive functions
Time Frame: change from baseline after 12 months
Trail Making Test (TMT) score
change from baseline after 12 months
quality of life
Time Frame: change from baseline after 12 months
Dementia Quality of Life (D-QoL) Instrument
change from baseline after 12 months
coping strategies
Time Frame: change from baseline after 12 months
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
change from baseline after 12 months
caregiver quality of life
Time Frame: change from baseline after 8 weeks and after 12 months
Psychological Well-Being (PWB) scale
change from baseline after 8 weeks and after 12 months
caregiver coping strategies
Time Frame: change from baseline after 8 weeks and after 12 months
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
change from baseline after 8 weeks and after 12 months
caregiver burden
Time Frame: change from baseline after 8 weeks and after 12 months
Caregiver Burden Inventory (CBI)
change from baseline after 8 weeks and after 12 months
caregiver affect
Time Frame: change from baseline after 8 weeks and after 12 months
Positive and Negative Affect Schedule (PANAS)
change from baseline after 8 weeks and after 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

April 12, 2016

First Submitted That Met QC Criteria

April 20, 2016

First Posted (Estimate)

April 21, 2016

Study Record Updates

Last Update Posted (Estimate)

January 18, 2017

Last Update Submitted That Met QC Criteria

January 16, 2017

Last Verified

January 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Ability platform program

3
Subscribe